Bionano Genomics Inc BNGO:NASDAQ

Last Price$3.40NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.46 (2)
Ask (Size)$3.47 (3)
Day Low / HighN/A - N/A
Volume14.2 M
 

View Biotechnology IndustryPeer Comparison as of 12/03/2021

 

Bionano Genomics Inc ( NASDAQ )

Price: $3.40
Change: -0.31 (8.36%)
Volume: 14.2 M
4:00PM ET 12/03/2021
 
 

Seres Therapeutics Inc ( NASDAQ )

Price: $10.68
Change: -0.75 (6.56%)
Volume: 2.5 M
4:00PM ET 12/03/2021
 
 

MacroGenics Inc ( NASDAQ )

Price: $16.40
Change: -0.93 (5.37%)
Volume: 582.0 K
4:00PM ET 12/03/2021
 
 

MannKind Corp ( NASDAQ )

Price: $4.17
Change: -0.25 (5.66%)
Volume: 2.8 M
4:00PM ET 12/03/2021
 
 

Vanda Pharmaceuticals Inc ( NASDAQ )

Price: $16.22
Change: -0.35 (2.11%)
Volume: 431.8 K
4:00PM ET 12/03/2021
 

Read more news Recent News

BioNano Genomics Says Johns Hopkins University Study Backs Use of Optical Genome Mapping in Cancer
10:25AM ET 11/22/2021 MT Newswires

BioNano Genomics (BNGO) said Monday a study by the Johns Hopkins University supporting the use of optical genome mapping in cancer analysis has been...

Bionano Genomics to Buy BioDiscovery
8:23AM ET 10/12/2021 MT Newswires

Bionano Genomics (BNGO) said Tuesday it has agreed to purchase BioDiscovery, a software company that offers services for analysis, interpretation and...

Bionano Genomics Says Optical Genome Mapping Cited in Peer-Reviewed Studies
1:58PM ET 7/07/2021 MT Newswires

Bionano Genomics (BNGO) said Wednesday its optical genome mapping technology was cited in two peer-reviewed studies published in the American Journal of...

--BTIG Starts Bionano Genomics at Buy With $10 Price Target
6:47AM ET 6/16/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionBionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA. View company web site for more details
Address9540 Towne Centre Drive
San Diego, California 92121
Phone+1.858.888.7600
Number of Employees77
Recent SEC Filing12/01/20214
President, CEO, Secretary & DirectorRobert Erik Holmlin
Chief Operating OfficerMark Oldakowski
Chief Financial & Accounting OfficerChristopher Stewart
Chief Medical OfficerAlka Chaubey

Company Highlights

Price Open$3.68
Previous Close$3.71
52 Week Range$0.49 - 15.69
Market Capitalization$983.2 M
Shares Outstanding289.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/22/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.24
Beta vs. S&P 500N/A
Revenue$12.0 M
Net Profit Margin-390.68%
Return on Equity-22.56%

Analyst Ratings as of 06/15/2021

Buy
4
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset